LLY
stock·AFTER-HOURSNYSE/NASDAQEli Lilly — Pharma leader in diabetes and weight-loss drugs (Mounjaro, Zepbound).
loading charts…
News
8| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | LLYUSDT | 1,163.36 | 1,162.66 | +6.0 bps | --:--:--+0.0000%(+0.00% ann) | $18.5M | 55.1% | $1.69M | 65d |
 xyz | LLY-USDC | 1,162.40 | 1,162.40 | +0.0 bps | --:--:--+0.0006%(+5.47% ann) | $7.65M | 22.8% | $2.83M | 139d |
 | LLY-USDT-SWAP | 1,164.00 | — | — | --:--:--+0.0000%(+0.00% ann) | $2.79M | 8.3% | $405.12K | 100d |
 | LLYUSDT | 1,165.16 | 1,163.44 | +14.8 bps | --:--:--+0.0074%(+8.13% ann) | $1.98M | 5.9% | $2.34M | 86d |
 | LLYSTOCK_USDT | 1,163.76 | 1,163.12 | +5.5 bps | --:--:--+0.0000%(+0.00% ann) | $1.61M | 4.8% | $2.54M | 148d |
 | LLY_USDT | 1,163.01 | 1,162.95 | +0.5 bps | --:--:--+0.0100%(+10.95% ann) | $738.86K | 2.2% | $422.79K | 188d |
| backed | LLYX_USDT | 1,167.35 | — | — | — | $164.62K | 0.5% | — | 212d |
 ondo | LLYon | 1,162.21 | — | — | — | $58.02K | 0.2% | — | 178d |
 ondo | LLY | 1,163.12 | 1,159.17 | +34.0 bps | — | $57.78K | 0.2% | — | ≥365d |
| okx | XLLY-USDT | 1,160.00 | — | — | — | $13.32K | 0.0% | — | 12d |
 robinhood | LLY | 1,172.18 | 1,162.69 | +81.7 bps | — | $2.47K | 0.0% | — | 13d |
 | LLYUSDT | — | — | — | --:--:--+0.0000%(+0.00% ann) | — | — | $820.8K | 268d |
 backed | Xsnuv4…i6gKMH | 1,162.49 | 1,157.38 | +44.1 bps | — | — | — | — | 178d |